BFS
NVO

Bradley Foster & Sargent’s Novo Nordisk NVO Stock Holding History

Bradley Foster & Sargent’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Buy
46,963
+3
+0% +$129 0.03% 226
2026
Q1 		$1.73M Buy
46,960
+272
+0.6% +$12.9K 0.03% 240
2025
Q4 		$2.38M Sell
46,688
-1,327
-3% -$67.9K 0.03% 200
2025
Q3 		$2.66M Sell
48,015
-7,975
-14% -$467K 0.04% 197
2025
Q2 		$3.86M Buy
55,990
+6,341
+13% +$431K 0.06% 174
2025
Q1 		$3.45M Sell
49,649
-8,115
-14% -$670K 0.06% 168
2024
Q4 		$4.97M Sell
57,764
-1,722
-3% -$186K 0.08% 146
2024
Q3 		$7.08M Sell
59,486
-7,758
-12% -$1.03M 0.12% 128
2024
Q2 		$9.6M Buy
67,244
+2,977
+5% +$394K 0.17% 103
2024
Q1 		$8.25M Buy
64,267
+961
+2% +$114K 0.15% 114
2023
Q4 		$6.55M Buy
63,306
+28,770
+83% +$2.85M 0.13% 123
2023
Q3 		$5.59M Sell
34,536
-34,536
-50% -$3.04M 0.12% 130
2023
Q2 		$5.59M Buy
69,072
+308
+0.4% +$25.2K 0.12% 130
2023
Q1 		$5.47M Sell
68,764
-4,050
-6% -$287K 0.13% 117
2022
Q4 		$4.93M Hold
72,814
– – 0.12% 121
2022
Q3 		$3.63M Sell
72,814
-430
-0.6% -$23K 0.1% 136
2022
Q2 		$4.08M Buy
73,244
+1,360
+2% +$75.5K 0.11% 131
2022
Q1 		$3.99M Sell
71,884
-300
-0.4% -$15.4K 0.09% 153
2021
Q4 		$4.04M Sell
72,184
-1,074
-1% -$58.2K 0.08% 148
2021
Q3 		$3.52M Buy
73,258
+816
+1% +$39.4K 0.08% 144
2021
Q2 		$3.03M Buy
72,442
+1,224
+2% +$47.4K 0.07% 155
2021
Q1 		$2.4M Sell
71,218
-142
-0.2% -$5.06K 0.06% 169
2020
Q4 		$2.49M Buy
71,360
+900
+1% +$31.1K 0.07% 155
2020
Q3 		$2.45M Buy
+70,460
New +$2.35M 0.07% 145
2020
Q1 		$2.12M Sell
70,282
-50
-0.1% -$1.49K 0.08% 138
2019
Q4 		$2.04M Buy
70,332
+690
+1% +$19.1K 0.06% 164
2019
Q3 		$1.8M Sell
69,642
-1,050
-1% -$26.6K 0.06% 167
2019
Q2 		$1.8M Sell
70,692
-4,800
-6% -$119K 0.06% 173
2019
Q1 		$1.97M Hold
75,492
– – 0.07% 166
2018
Q4 		$1.74M Sell
75,492
-3,000
-4% -$66.7K 0.07% 167
2018
Q3 		$1.85M Buy
78,492
+66,800
+571% +$1.63M 0.06% 180
2018
Q2 		$270K Hold
11,692
– – 0.01% 333
2018
Q1 		$288K Buy
11,692
+42
+0.4% +$1.1K 0.01% 314
2017
Q4 		$313K Sell
11,650
-934
-7% -$23.8K 0.01% 303
2017
Q3 		$303K Sell
12,584
-258
-2% -$5.83K 0.01% 307
2017
Q2 		$275K Buy
+12,842
New +$259K 0.01% 316
2017
Q1 		– Sell
-16,602
Closed -$298K – 350
2016
Q4 		$298K Sell
16,602
-64,916
-80% -$1.18M 0.01% 296
2016
Q3 		$1.7M Buy
81,518
+3,140
+4% +$77.9K 0.07% 160
2016
Q2 		$2.11M Buy
78,378
+1,316
+2% +$36.1K 0.09% 137
2016
Q1 		$2.09M Buy
77,062
+6,220
+9% +$167K 0.1% 142
2015
Q4 		$2.06M Buy
70,842
+3,320
+5% +$91.9K 0.09% 147
2015
Q3 		$1.83M Buy
67,522
+4,250
+7% +$120K 0.09% 149
2015
Q2 		$1.73M Buy
63,272
+11,760
+23% +$331K 0.08% 160
2015
Q1 		$1.38M Buy
51,512
+10,786
+26% +$248K 0.06% 172
2014
Q4 		$862K Buy
40,726
+5,110
+14% +$114K 0.04% 199
2014
Q3 		$848K Buy
35,616
+9,400
+36% +$216K 0.04% 208
2014
Q2 		$605K Buy
26,216
+6,200
+31% +$137K 0.03% 225
2014
Q1 		$457K Sell
20,016
-4
-0% -$85 0.02% 249
2013
Q4 		$370K Buy
20,020
+200
+1% +$3.48K 0.02% 274
2013
Q3 		$335K Buy
19,820
+1,310
+7% +$22K 0.02% 273
2013
Q2 		$287K Buy
+18,510
New +$308K 0.02% 276

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bradley Foster & Sargent's NVO Position: Q2 2026 in Review

Bradley Foster & Sargent increased its Novo Nordisk (NVO) stake by 0.01% in Q2 2026, buying an estimated $129 and bringing the position to 46,963 shares worth $2.25M. The position accounts for 0.03% of the portfolio, ranked #226.

Bradley Foster & Sargent first reported a position in NVO in Q2 2013 and has held it in 51 quarters since. The position peaked at $9.6M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Bradley Foster & Sargent held 46,963 shares of Novo Nordisk worth $2.25M as of Q2 2026.
  • Bradley Foster & Sargent bought 3 Novo Nordisk shares in Q2 2026, an estimated $129.
  • Novo Nordisk made up 0.03% of Bradley Foster & Sargent's portfolio in Q2 2026, its #226 holding.
  • Bradley Foster & Sargent first reported a position in Novo Nordisk in Q2 2013 and has held it in 51 quarters since.
  • Bradley Foster & Sargent's Novo Nordisk position peaked at $9.6M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.